The US regulator has cleared TROP2-directed ADC datopotamab deruxtecan (Dato-DXd) under the Datroway trade name as a ...
DATROWAY Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer ...
Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...
Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...
Even with the same cancer diagnosis personalised treatments are essential due to variations in patient health cancer ...
Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer ...
"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...
Dr. Liz O'Riordan wants people to know that there is no "magic fix" and no special diet that will cure cancer, despite many of the online claims out there.
Alarming rates of secondary breast cancer are on the rise, with the figure increasing year on year since 2018 so it's more important than ever to know where it is most likely to occur and what to look ...
Susan G. Komen: Quality of Life After Breast Cancer Treatment. National Cancer Institute: Complementary and Alternative ...
DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+ or ...